Infectious disease companies develop technologies, diagnostics and therapeutics that prevent, detect and treat bacterial, viral, fungal and parasitic infections. Their work supports global health, outbreak response and disease surveillance.
This category includes companies working on:
Browse 118 UK infectious disease companies below.
Thermostable vaccine platform eliminating cold chain dependency
Stablepharma is a clinical-stage biotechnology company developing fridge-free vaccines and biologicals using. Its technology reformulates temperature-sensitive products into thermostable formulations that remain potent without refrigeration. The technology addresses cold chain failure, which the WHO estimates causes…
Global specialist pharmaceutical company focused on HIV
ViiV Healthcare is a specialist pharmaceutical company dedicated to the research, development, and commercialisation of medicines for HIV treatment and prevention. Its portfolio includes widely used antiretroviral therapies such as Dovato and the long-acting injectable Cabenuva, and it is advancing next-generation…
T cell immunotherapies for infectious disease, cancer and autoimmunity
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing antigen-specific T cell immunotherapies for chronic infectious diseases, autoimmune conditions, and cancer. Its pipeline is built on four proprietary viral vector and synthetic immunotherapy platforms and includes clinical candidates…
Drug-free nasal barrier spray blocking airborne viruses and allergens
Birmingham Biotech is a University of Birmingham spin-out selling NoriZite, a drug-free nasal spray that creates a structured fluid-gel barrier in the nasal cavity for up to six hours, trapping airborne viruses, allergens and particulate pollution at the point of entry. The dual-polymer matrix formulation, developed…
Portable PCR diagnostics for high-consequence infectious diseases
BioGene develops portable real-time PCR instruments and diagnostic reagents for detecting infectious pathogens. Its extraction-free, freeze-dried chemistry is designed to detect pathogens directly from crude samples in under 30 minutes, reducing the need for conventional laboratory preparation. The company's assays…
Global commercialisation of specialty, hospital and rare disease medicines
ADVANZ PHARMA is a global pharmaceutical company focused on the commercialisation of specialty, hospital and rare disease medicines, partnering with biopharma and pharmaceutical development companies to bring treatments to patients. The company's portfolio spans therapeutic areas including hepatology,…
Bacillus spore-based vaccines, drug delivery and probiotic therapeutics developer
SporeGen is a biotechnology company working exclusively on spore-forming Bacillus bacteria to develop vaccines, drug delivery platforms and probiotic therapeutics. The company's SporeVax platform uses bacterial spores as a vaccine delivery agent, and its SPOR-COV nasal spray, developed with a commercial partner, aims…
Plasmonic PCR diagnostics for rapid infectious disease detection
RapidX Bio is a biotechnology company developing point-of-care molecular diagnostics for infectious diseases. Its plasmonic PCR technology uses light-responsive gold nanorods to accelerate nucleic acid amplification and reduce sample preparation requirements. The company is developing portable tests to identify…
Molecular serotyping microarrays and surveillance services for vaccine pathogens
BUGS Bioscience is a not-for-profit biotechnology spin-out of the Bacterial Microarray Group at St George's, University of London. The company develops and provides molecular serotyping microarray platforms and associated genomic surveillance services for vaccine-preventable bacterial pathogens, including…
Birthplace of molecular biology researching fundamental processes in human disease
The MRC Laboratory of Molecular Biology researches fundamental biological processes at the level of atoms, molecules, cells and organisms, applying this knowledge to major problems in human health and disease. The Laboratory pioneered techniques including DNA sequencing, protein structure determination and the…
Broad-spectrum intranasal antivirals targeting respiratory viral infections
Pneumagen is a Scottish clinical-stage biotechnology company developing broad-spectrum intranasal antiviral therapies. Pneumagen's platform generates multivalent carbohydrate binding molecules (mCBMs) that block viral entry by binding to sialic acid residues on host epithelial cells. In 2026, Pneumagen reorganized…
Novel mRNA technology platform for safer, faster vaccines
CamMed Therapeutics (Cambridge Medixine Ltd) is a preclinical biotechnology company developing a novel mRNA technology platform for vaccines and therapeutics. Inspired by natural biological phenomena, its engineered RNA molecules are designed to deliver safer, easier and faster medicines to the clinic while reducing…
CRO specialising in human challenge trials
hVIVO is a specialist contract research organisation providing human challenge trial services for infectious and respiratory disease. The company conducts controlled human infection studies across more than 14 validated viral challenge models, supporting the development of vaccines and antivirals for clients including…
Portable PCR platform for decentralised genetic testing anywhere
Hyris is a biotechnology company developing a portable, IoT-integrated PCR platform for decentralised nucleic acid testing outside traditional laboratory settings. Its instrument runs proprietary assay cartridges and connects to a cloud-based software platform providing real-time results via a dedicated app. An open…
Infectious disease research platforms and industry-academic partnerships
iiCON (Infection Innovation Consortium) is a Liverpool-led research partnership accelerating the discovery and development of infectious disease interventions. Led by Liverpool School of Tropical Medicine, it connects industry, academia and the NHS through specialist platforms covering antimicrobial discovery,…
Ultra-fast PCR point-of-care diagnostics from swab to result
LEX Diagnostics is a molecular diagnostics company developing rapid point-of-care PCR testing through its proprietary thermal cycling platform. Its system delivers quantitative PCR results directly from a dry swab in six to ten minutes with no sample preparation, targeting respiratory infections including influenza…
Synthetic mycolic acid antigens and point-of-care TB diagnostics
Diagnostig is a Welsh diagnostics and chemical synthesis company developing point-of-care immunoassay devices for the diagnosis of mycobacterial infections, including human and bovine tuberculosis. The company's technology is based on fully synthetic mycolic acids, chemically defined cell wall components unique to…
Rapid point-of-care antibiotic susceptibility testing for antimicrobial resistance
Microplate Dx is a diagnostics biotechnology company developing a rapid antibiotic susceptibility testing platform for use at the point of care. Its biosensor technology uses hydrogel-modified electrodes loaded with antibiotics to determine the most effective treatment for a patient's bacterial infection in under one…
Natural antimicrobial solutions to reduce livestock antibiotic use
Feed, Food & Future is a life sciences company developing and testing natural antibacterial and antiviral ingredients for the animal feed and livestock industries. Operating from a BSL2 laboratory at Cardiff Medicentre, the company researches plant-based and natural molecules as alternatives to conventional…
Specialty pharma delivering niche medicines and novel drug delivery technology
Therakind is a specialty pharmaceutical company focused on developing niche medicines for difficult-to-treat patient populations, including children and the elderly. The company has obtained regulatory approvals for three products across the FDA, EMA and MHRA, and has developed a proprietary intranasal dry powder…